Science Explorer Back to mapMap
Discussion
Researcher · AiCuris (Germany) · Germany

Helga Ruebsamen‐Schaeff

Helga Ruebsamen‐Schaeff publishes mostly in Epidemiology, Infectious Diseases and Genetics, on topics such as Herpesvirus Infections and Treatments, Cytomegalovirus and herpesvirus research and Virus-based gene therapy research.

ORCID 0000-0002-5464-662X OpenAlex
World rank
#1,340,885
of 7,710,434 ranked researchers
Rank in Germany
#66,075
of 364,343
Works
24
Citations
1.5k
Citations per work
61.0
h-index
16
i10-index 16Top 32% in Epidemiology
Helga Ruebsamen‐Schaeff

What does Helga Ruebsamen‐Schaeff research?

Helga Ruebsamen‐Schaeff's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (12%).

Health Sciences: 17 works · 69.4% of their workMedicine: 17 works · 69.4% of their workEpidemiology: 10 works · 43.5% of their workInfectious Diseases: 3 works · 13.0% of their workCardiology and Cardiovascular Medicine: 1 works · 4.3% of their workHepatology: 1 works · 4.3% of their workPublic Health, Environmental and Occupational Health: 1 works · 4.3% of their workEverything else: 5 works · 19.0% of their workLife Sciences: 3 works · 11.6% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.6% of their workGenetics: 3 works · 11.6% of their workTHEIR WORKHelgaRuebsamen‐Schaeff24works
Life Sciences12%Health Sciences69%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1769.4%
  2. Everything else519.0%
    1. Biochemistry, Genetics and Molecular Biology311.6%
  1. 1Epidemiology44% of their works
  2. 2Infectious Diseases13% of their works
  3. 3Genetics12% of their works
  4. 4Cardiology and Cardiovascular Medicine4% of their works
  5. 5Public Health, Environmental and Occupational Health4% of their works
  6. 6Hepatology4% of their works

Research topics

Which keywords describe Helga Ruebsamen‐Schaeff's research?

The keywords of their largest research topics: Immune Response, Epidemiology, Vaccine, Antiviral Therapy, Herpes Zoster, Herpesviruses, Cytomegalovirus and Infection.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Immune Response254 topics
  2. Epidemiology234 topics
  3. Vaccine172 topics
  4. Antiviral Therapy163 topics
  5. Herpes Zoster151 topic
  6. Herpesviruses151 topic
  7. Cytomegalovirus81 topic
  8. Infection81 topic
  9. Liver Disease82 topics
  10. Gene Therapy71 topic
  11. Viral Vectors71 topic
  12. Chronic Hepatitis B51 topic
  13. Hepatitis B Virus51 topic
  14. Antiretroviral Therapy31 topic
  15. HIV Infection31 topic
  16. Hepatitis C Virus31 topic
  17. Myocarditis31 topic
  18. Treatment31 topic
  19. Viral Infection31 topic
  20. Coronavirus21 topic
  21. Porcine Reproductive and Respiratory Syndrome Virus21 topic

Where does Helga Ruebsamen‐Schaeff work?

Helga Ruebsamen‐Schaeff's main affiliation in the publication record is AiCuris (Germany), Germany.

How many publications and citations does Helga Ruebsamen‐Schaeff have?

OpenAlex counts 24 works and 1,465 citations for Helga Ruebsamen‐Schaeff, an h-index of 16, ranking #1,340,885 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Helga Ruebsamen‐Schaeff. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.